Unlock instant, AI-driven research and patent intelligence for your innovation.

Substituted steroid compound and application thereof

A technology of compounds and steroids, applied in the field of steroids and their uses, can solve the problems of stimulating tumor growth and inability to inhibit androgen, and achieve increased drug concentration, good pharmacokinetic parameter characteristics, and excellent inhibitory properties Effect

Active Publication Date: 2021-05-28
SHENZHEN TARGETRX INC
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In men with prostate cancer, the hormone testosterone stimulates tumor growth. Castration therapy, including drugs or surgery, can reduce testosterone production or block the effects of testosterone, but this treatment does not suppress androgen production elsewhere in the body , prostate cancer can continue to grow

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Substituted steroid compound and application thereof
  • Substituted steroid compound and application thereof
  • Substituted steroid compound and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061]Example 1 Preparation 3β-17- (1H-benzo [D] imidazole-2-D-1-yl)-5,16-diene-3-alcohol (compound 7)

[0062]

[0063]Step 1: (3β) -3- (acetyloxy) -17-chlorine-5,16-diene-16-formaldehyde (Compound 2) was synthesized.

[0064]N, N-dimethylformamide (15 ml, 192 mmol) under an ice bath was slowly added dropwise to chloroform (15 mL, 165 mmol) chloroform (45 mL) solution. After the dropwise addition, the chloride (3.00 g, 9.00 mmol) chloroform (45 mL) solution was slowly added dropwise. After the dropwise addition, heated to room temperature, reflux reaction 5HRS. The reaction solution was concentrated under reduced pressure, and the residue was added to ice water, mixed with diethyl ether / ethyl acetate (8 / 2, v / v), combined with a organic layer, washed with saturated brine, dried over anhydrous sodium sulfate. The organic layer was concentrated under reduced pressure, and the concentrated liquid column chromatography was purified from 2.10 g of meter solid, yield: 62.0%. LC-MS (APCI): M / ...

Embodiment 2

[0073]Example 2 Preparation 3β-17- (1H-benzo [D] imidazole-5, 6, 7-d 3-1-yliocrastivheto-5,16-diene-3-alcohol (chemical 合 13)

[0074]

[0075]At room temperature, nitrogen protects anhydrous dimethyl sulfoxide (6 mL) solution to 17-iodine-5,16-diene-3β-alcohol (300 mg, 0.75 mmol), 1H-benzo [D] imidazole- 4, 5, 6, 7-d4(110 mg, 0.90 mmol), L-proline (35 mg, 0.3 mmol), copper (30 mg, 0.15 mmol) and potassium carbonate (259 mg, 1.87 mmol) mixture were overnight at 120 ° C. Cooled to room temperature, add water (25 mL) to quench the reaction, diatomite filtration, and the filtrate was extracted with ethyl acetate (30 mLx 3), combined with organic layers, washed with saturated saline (30 mL), dry alhydrate sodium sulfate, The organic layer was concentrated under reduced pressure, and the concentrated liquid column chromatography was purified from 80 mg of white solid, yield: 27.2%, purity: 99.37%. LC-MS (APCI): M / Z = 393.0 [M + 1]+;1H NMR (300 MHz, MeOD-D) (δ / ppm) 8.18 (S, 1H), 6.08 (DD, ...

Embodiment 3

[0076]Example 3 Preparation 3β-17- (1H-benzo [D] imidazole-4, 5, 6, 7-d 4 -1-yliocomposites - 5,16-diene-3-alcohol(Compound 15)

[0077]

[0078]At room temperature, nitrogen protects anhydrous dimethyl sulfoxide (6 mL) solution to 17-iodine-5,16-diene-3β-alcohol (300 mg, 0.75 mmol), 1H-benzo [D] imidazole- 4, 5, 6, 7-d4(110 mg, 0.90 mmol), L-proline (35 mg, 0.3 mmol), copper (30 mg, 0.15 mmol) and potassium carbonate (259 mg, 1.87 mmol) mixture were overnight at 120 ° C. Cooled to room temperature, add water (25 mL) to quench the reaction, diatomite filtration, and the filtrate was extracted with ethyl acetate (30 mLx 3), combined with organic layers, washed with saturated saline (30 mL), dry alhydrate sodium sulfate, The organic layer was concentrated under reduced pressure, and the concentrated liquid column chromatography was purified from 80 mg of white solid, yield: 27.2%, purity: 99.37%. LC-MS (APCI): M / Z = 393.0 [M + 1]+;1H NMR (300 MHz, MeOD-D) (δ / ppm) 8.18 (S, 1H), 6.08 (DD...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a substituted steroid compound and application thereof. Specifically, the substituted steroidal compound is a steroidal compound as shown in formula (I), or a crystal form, a pharmaceutically acceptable salt, a prodrug, a stereoisomer, a hydrate or a solvent compound thereof. The substituted steroid compound and the composition containing the compound disclosed by the invention have excellent inhibition on CYP17 enzyme and androgen receptor (AR), have better pharmacokinetic parameter characteristics, and can improve the drug concentration of the compound in animal bodies so as to improve the drug curative effect and safety.

Description

[0001]This application is filed December 29, 2016, Application No. 201680065029.5, entitled "one substituted steroid compounds and their application" divisional application of the present invention patent application.Technical field[0002]The invention belongs to the medical field. In particular, the present invention relates to steroid compounds and their use, more particularly, relates to steroid compounds and their use as irreversible inhibitors of the enzyme CYP17 and androgen receptor (AR) antagonists, useful in the treatment and prevention of CYP17 Enzymes and androgen receptors (AR) related diseases.Background technique[0003]Prostate Cancer, English is a PCA) is a common malignant tumor common male reproductive system. In 2008, there were 903,500 cases of premium prostate cancer and 25,8400 pre-prostate cancer death cases. New cases of prostate cancer which accounts for 14% of all new cases of male cancer, male cancer new cases ranked No. 2; prostate cancer deaths accounted fo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07J43/00C07B59/00A61K31/58A61P35/00A61P29/00A61P31/00A61P37/06A61P37/02A61P31/12A61P9/00A61P3/00
CPCC07J43/003C07B59/007C07B2200/05A61K31/58C07B59/00C07J43/00
Inventor 王义汉任兴业
Owner SHENZHEN TARGETRX INC